1. WHO Classification of Tumours of Lymphoid and Hematopoietic Tissues. Lyon : IARC, 2017. 585 p.
2. Hallek M., Cheson B.D., Catovsky D. et al.; International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines // Blood. 2008. Vol. 111. P. 5446–5456.
3. Tooze J.A., Hamzic E., Willis F. et al. Differences between chronic lymphocytic leukemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis // Cancer Genet. 2017. Vol. 218. P. 20–38.
4. Giné E., Martinez A., Villamor N. et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia («accelerated» chronic lymphocytic leukemia) with aggressive clinical behavior // Haematologica. 2010. Vol. 95, N 9. P. 1526–1533.
5. Richter M.N. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia // Am. J. Pathol. 1928. Vol. 4. P. 285–292.
6. Rossi D., Spina V., Deambrogi C., Rasi S., Laurenti L., Stamatopoulos K. et al. The genetics of Richter’s syndrome reveals disease heterogeneity and predicts survival after transformation // Blood. 2011. Vol. 117, N 12. P. 3391–3401.
7. Mao Z., Quintanilla-Martinez L., Raffeld M., Richter M., Krugmann J., Burek C. et al. IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent two different pathways of evolution // Am. J. Surg. Pathol. 2007. Vol. 31, N 10. P. 1605–1614.
8. Bockorny B., Codreanu I., Dasanu CA. Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature // Br. J Haematol. 2012. Vol. 156, N 1. P. 50–66.
9. Martinez D., Valera A., Perez N.S., Sua Villegas L.F., Gonzalez-Farre B., Sole C. et al. Plasmablastic transformation of low-grade B-cell lymphomas. Report on 6 cases // Am. J. Surg. Pathol. 2013. Vol. 37, N 2. P. 272–280.
10. Martinez A., Pittaluga S., Villamor N. et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis // Am. J. Surg. Pathol. 2004. Vol. 28. P. 849–858.
11. Foo W.C., Huang Q., Sebastian S., Hutchinson C.B., Burchette J., Wang E. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B-cells by Epstein-Barr virus // Hum. Pathol. 2010. Vol. 41. P. 1802–1808.
12. Bernardo A.D., Mussetti A., Aiello A. et al. Alternate clonal dominance in Richter transformation presenting as extranodal diffuse large B-cell lymphoma and synchronous classic Hodgkin Lymphoma // Am. J. Clin. Pathol. 2014. Vol. 142. P. 227–232. DOI: https://doi.org/10.1309/AJCP4T9RPXYTXQDE
13. Kanzler H., Kuppers R., Helmes S. et al. Hodgkin and Reed-Sternberg-like cells in B-cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin’s disease // Blood. 2000. Vol. 95. P. 1023–1031.
14. He R., Ding W., Viswanatha DS et al. PD-1 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and large B-cell Richter transformation (DLBCL-RT) a characteristic feature of DLBCL-RT and potential surrogate marker for clonal relatedness // Am. J. Surg. Pathol. 2018. Vol. 42, N 7. P. 843–854. DOI: https://doi.org/10.1097/PAS.0000000000001077
15. Wang L., Shalek A.K., Lawrence M. et al. Somatic mutation as a mechanism of Wnt/b-catenin pathway activation in CLL // Blood. 2014. Vol. 124. P. 1089–1098.
16. Tandon B., Peterson L., Gao J. et al. Nuclear overexpression of lymphoid enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas // Mod. Pathol. 2011. Vol. 24. P. 1433–1443.
17. Autore А., Strati P. , Laurenti L. et al. Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review // Haematologica. 2018. Vol. 103, N 6. P. 931–938.
18. Ho A., Hill S., Preobrazhensky S. et al. Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias // Am. J. Clin. Pathol. 2009. Vol. 131. P. 27–32.
19. Schlette E., Fu K., Medeiros L.J. CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases // Am. J. Clin. Pathol. 2003. Vol. 120. P. 760–766.
20. Barna G., Reiniger L., Tátrai P. et al. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL // Hematol. Oncol. 2008. Vol. 26. P. 167–170.
21. Saksena A., Yin C.C., Xu J. et al. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis // Hum. Pathol. 2019. Vol. 89. P. 71–80.
22. Yoshino T., Tanaka T., Sato Y. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma // J. Clin. Exp. Hematopathol. 2020. Vol. 60, N 2. P. 1–6. DOI: https://doi.org/10.3960/jslrt.19041
23. Nieto W.G., Almeida J., Romero A. et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach // Blood. 2009. Vol. 114, N 1. P. 33–37.